NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Clinical trials for NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lung cancer combo aims to outperform current standard
Disease control Not yet recruitingThis study tests a new drug called HB0025 combined with chemotherapy against the current standard treatment (tislelizumab plus chemo) for people with advanced nonsquamous non-small cell lung cancer that cannot be removed by surgery. About 500 participants will receive either the …
Matched conditions: NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
New drug duo takes on advanced cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new combination of two drugs, risvutatug rezetecan and ivonescimab, in about 184 adults with advanced solid tumors that have spread. The main goals are to find safe dose levels, check for side effects, and see if the combination can shrink tumors. T…
Matched conditions: NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC
-
New drug IDP-001 tested against advanced cancers
Disease control Not yet recruitingThis study tests a new drug called IDP-001 in people with advanced or spreading solid tumors, including lung, head and neck, esophageal, cervical, and skin cancers. The goal is to see if the drug is safe, how the body processes it, and whether it can shrink tumors. About 132 adul…
Matched conditions: NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: InduPro, Inc. • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC